China has eased some of its steep tariffs on U.S. goods, especially pharmaceuticals, This move comes amid rising pressure from U.S. trade policies and suggests a potential shift in the ongoing U.S.-China trade war. Business groups confirmed that some American-made drugs are now entering China without paying the 125% tariffs imposed earlier this month. Those duties were a response to President Trump’s 145% tariffs on Chinese imports.
In addition, a list of 131 U.S. product categories—including vaccines, chemicals, and jet engines is said to be under review for tariff exemptions. Though China hasn’t confirmed the list, sources within trade circles say it’s a possible sign of flexibility. The easing of China tariffs on U.S. goods may signal attempts to calm global economic tensions.
Trump Talks Big on Trade, But China Pushes Back
President Trump claimed in an interview with TIME that he had spoken with Chinese President Xi Jinping and secured “200 trade deals” to be finalized within weeks. “I don’t think it’s a sign of weakness on his behalf,” Trump said confidently. However, China quickly shut down the claims.
In a post on social media, the Chinese Embassy in Washington stated, “China and the U.S. are NOT having any consultation or negotiation on #tariffs. The U.S. should stop creating confusion.” The denial has raised doubts about whether the easing of China tariffs on U.S. goods is part of any active negotiation or just a strategic move by Beijing.
Trump also said that talks with Japan were nearly complete. Analysts see the Japan deal as a test case for how the U.S. may handle future bilateral trade agreements, especially as the July 9 tariff suspension deadline approaches.
Markets React, But Risks Remain
While European and Asian stocks rose in response to hopes of eased tensions, U.S. markets remain under stress. Since Trump returned to office, U.S. stocks have dropped by 10%. The dollar has also faced serious volatility.
Economists have warned that the new wave of tariffs including those on pharmaceuticals and semiconductors could drive U.S. drug prices up by 12.9%. Many say Trump’s trade barriers could push the U.S. closer to a recession. His administration’s tariff policy was a major discussion point during the recent IMF and World Bank meetings.
South Korea and Switzerland both reported early progress in talks with U.S. Treasury Secretary Scott Bessent. Yet, overall, few countries have achieved real results. IMF head Kristalina Georgieva warned that prolonged trade wars like the U.S.-China standoff could seriously damage global economic growth.
Uncertainty Lingers Despite Tariff Lift
Although China has lifted some tariffs on U.S. goods, it continues to reject Trump’s claims about ongoing trade negotiations. The gesture appears strategic but does not signal a breakthrough. Until official talks begin, the easing of China tariffs on U.S. goods remains just one piece of a larger, uncertain puzzle.
China Tariffs on U.S. Goods Eased but Talks Denied
While the easing of China tariffs on U.S. goods is a hopeful development for some industries, the lack of confirmed negotiations casts a long shadow. President Trump’s claims of progress are being flatly denied by China, creating mixed signals in an already fragile trade environment. As businesses await clarity, the real question is whether tariff relief will lead to real trade resolution or just more headlines.
